231 Molecular insights on safety and anti-tumor activity of a non-irAE-inducing anti-CTLA-4 monoclonal antibody ONC-392

• Yang Liu,
• Yan Zhang,
• Pan Zheng,
• Xuexiang Du,
• Mingyue Liu,
• Xianfeng Fang,
• Libing Mu,
• Vadim Tevetnitsky,
• Martin Devenport

Affiliations

Yang Liu

Radiology, Mayo Clinic, Rochester, Minnesota, USA

Yan Zhang

Department of cardiology, Peking University First Hospital, Beijing, China

Pan Zheng

Division of Immunotherapy, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA

Xuexiang Du

3University of Maryland Baltimore, Jinan, China

Mingyue Liu

3University of Maryland Baltimore, Jinan, China

Xianfeng Fang

4AcroImmune, Ltd, Guangzhou, China

Libing Mu

4AcroImmune, Ltd, Guangzhou, China

Vadim Tevetnitsky

1OncoC4, Inc., Rockville, MD, United States

Martin Devenport

1OncoC4, Inc., Rockville, MD, United States